Clinical Potential

  1. In order to provide advice on the clinical potential for PharmNovo’s delta opioid receptor agonists, Professor Andrew Rice from Imperial College London has agreed to become a consultant to the team. Prof Rice is an internationally regarded clinical and scientific expert in the field of chronic pain.